HORMONE HEALTH · ADULT EDUCATION

Menopause & HRT conversation

Explore menopause symptoms, timing and safety questions before discussing treatment.

Evidence, method & limitations

Guideline-based questions with a custom non-validated symptom-impact summary; not an HRT eligibility score.

Published scales are distinguished from custom checklists. This website implementation has not been independently clinically validated or individually clinician-reviewed. Source organizations do not endorse this website.

HORMONE HEALTH · YOUR NEXT CONVERSATION

Feeling different?
Start with what you notice.

A guided check-in for men’s testosterone concerns and women’s perimenopause or menopause symptoms. One question at a time, with clear next steps.

A conversation guide—not an HRT eligibility score.

The 0–15 symptom-impact total is a custom, non-validated summary of five answers. It cannot diagnose hormone deficiency, estimate treatment benefit, recommend a dose or tell you that HRT is safe.

Answers stay in this page, are not saved, and are not attached to appointment texts or lab requests. Reload or restart to clear them.

Evidence & scoring method

Each symptom is rated 0 (none), 1 (mild), 2 (moderate) or 3 (severe). We add the five ratings, without diagnostic cutoffs. Medical history and fertility answers guide the discussion; this tool does not recommend a lab package. The clinical guidance—not this custom score—is evidence-based. No endorsement by the source organizations is implied.

Sources checked September 10, 2026. Tool requires clinic review before use in clinical decision-making.

WOMEN’S HEALTHQuestion 1 of 8
Is there anything here a clinician should review first?

Unexplained vaginal bleeding (especially after 12 months without periods), breast or other hormone-sensitive cancer, blood clots, stroke, heart attack or liver disease. This is not a complete safety screen.

All 10 questionnaires

Before you use the result